Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models
- 1 November 1990
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 11 (6) , 609-613
- https://doi.org/10.1016/0197-4580(90)90025-u
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CHOLINERGIC SIDE-EFFECTS OF TETRAHYDROAMINOACRIDINEThe Lancet, 1988
- Oral tacrine administration in middle-aged monkeys: Effects on discrimination learningNeurobiology of Aging, 1987
- Alzheimer's Drug Trial Put on HoldScience, 1987
- A visual recognition memory test for the assessment of cognitive function in aging and dementiaExperimental Aging Research, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- The effects of physostigmine and scopolamine on recognition memory in monkeysBehavioral and Neural Biology, 1986
- Effects of 4-Aminopyridine in Elderly Patients with Alzheimer’s DiseaseNew England Journal of Medicine, 1984
- Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile DementiaThe British Journal of Psychiatry, 1981
- Cholinomimetic Treatment Fails to Improve Memory DisordersNew England Journal of Medicine, 1980
- Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolaminePharmacology Biochemistry and Behavior, 1978